Silence Therapeutics plc - SLN
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | — | P | A | 2,000.0 | — | — | 11,825,861.0 | View | |
| Feb 13, 2026 | — | S | A | 2,000.0 | — | — | 11,819,861.0 | View | |
| Feb 13, 2026 | — | P | A | 20,000.0 | — | — | 11,825,861.0 | View | |
| Feb 13, 2026 | — | S | A | 20,000.0 | — | — | 11,805,861.0 | View | |
| Jan 06, 2026 | — | A | A | 90,000.0 | 0.0 | 0.0 | 90,000.0 | View | |
| Jan 06, 2026 | — | A | A | 90,000.0 | 0.0 | 0.0 | 90,000.0 | View | |
| Jan 06, 2026 | EVP and Chief R&D Officer | A | A | 300,000.0 | 0.0 | 0.0 | 300,000.0 | View | |
| Jan 06, 2026 | Chief Financial Officer | A | A | 375,000.0 | 0.0 | 0.0 | 375,000.0 | View | |
| Jan 06, 2026 | — | A | A | 90,000.0 | 0.0 | 0.0 | 90,000.0 | View | |
| Dec 22, 2025 | Interim PEO | A | A | 900,000.0 | 0.0 | 0.0 | 900,000.0 | View | |
| Dec 22, 2025 | — | A | A | 90,000.0 | 0.0 | 0.0 | 90,000.0 | View |